Company News: Boehringer Ingelheim

Share this article:
The Boehringer Ingelheim-backed Drive4COPD awareness campaign is getting a big response through its use of social media, the company said. The campaign, which launched two weeks ago, has generated 27,000 completions of a validated five-question screener available at Drive4COPD.com, along with 1,400 Facebook fans, 25,000 clicks on campaign images at photo sharing site Flickr, 140,000 search results and 14,500 Twitter followers who've been exposed to some 50 Tweets from the campaign's celebrity ambassadors.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.